Richard D. Truesdell, Jr.

Davis Polk advised the joint book-running managers in connection with the $162.4 million SEC-registered follow-on offering of 2,680,089 shares of Class A common stock of Hamilton Lane…

Davis Polk advised IHS Markit Ltd. in connection with its SEC-registered offering of an additional $350 million aggregate principal amount of its 4.250% senior notes due 2029. The…

Davis Polk advised the joint book-running managers in connection with the SEC-registered offering by Deciphera Pharmaceuticals, Inc. of 10,810,810 shares of common stock for gross proceeds…

Davis Polk advised Freeport-McMoRan Inc. (“FCX”) in connection with its SEC-registered offering of $1.2 billion of senior notes. The offering consisted of two tranches of senior notes,…

Davis Polk advised the sole bookrunner in connection with the $168 million SEC-registered secondary offering of 12,000,000 shares of Class A common stock of Hostess Brands, Inc. by certain…

Davis Polk advised the underwriters in connection with the SEC-registered offering of 5,750,000 shares of common stock of Stemline Therapeutics, Inc. for total gross proceeds of…

Davis Polk advised the sole book-running manager and representative of the underwriters in connection with the $70 million follow-on offering of 741,750 shares of common stock of Kinsale…

Davis Polk advised the sales agents in connection with an SEC-registered at-the-market offering by PTC Therapeutics, Inc. of its shares of common stock for up to an aggregate amount of $125…

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $110 million initial public offering of 7,857,145 shares of common stock by…

Davis Polk advised the underwriters in connection with the SEC-registered offering by The Medicines Company of 5,227,273 shares of common stock for approximately $172.5 million, which…